Prosecution Insights
Prosecution Insights
5 pending office actions • 2 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (60%) |
| §103 only | 1 (20%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLUMEL, BENJAMIN P | 1 | 70.7% | +30.6% |
| SPAINE, ROBERT FRANKLIN | 1 | 100.0% | +0.0% |
| MOREAU, NASHARA LOUISE | 1 | 100.0% | +0.0% |
| KARUNASENA, ENUSHA | 1 | 0.0% | +0.0% |
| CHEN, CATHERYNE | 1 | 37.4% | +18.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18544358 | COMPOSITION INCLUDING PROPOLIS AND SORBUS COMMIXTA AS ACTIVE INGREDIENTS FOR ALLEVIATING AND TREATING INFLAMMATORY DISEASES AND ALLERGIC DISEASES | MOREAU, NASHARA LOUISE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18485314 | NOVEL BACILLUS VELEZENSIS GYUN-1190 STRAIN AND USE THEREOF | KARUNASENA, ENUSHA | 19d overdue |
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 50d |
| 18611577 | DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS | BLUMEL, BENJAMIN P | — |
| 18594709 | ANTI-OBESITY COMPOSITION CONTAINING HEMP SEED EXTRACT AS ACTIVE INGREDIENT | SPAINE, ROBERT FRANKLIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 50d |
| 18611577 | DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS | BLUMEL, BENJAMIN P | — |
| Art Unit | Apps |
|---|---|
| 1655 | 3 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18611577 | DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS | BLUMEL, BENJAMIN P | — | §101§102§112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18594709 | ANTI-OBESITY COMPOSITION CONTAINING HEMP SEED EXTRACT AS ACTIVE INGREDIENT | SPAINE, ROBERT FRANKLIN | 1655 | §103§112Other | Final Rejection | — | Pending | Mar 04, 2024 |
| 18544358 | COMPOSITION INCLUDING PROPOLIS AND SORBUS COMMIXTA AS ACTIVE INGREDIENTS FOR ALLEVIATING AND TREATING INFLAMMATORY DISEASES AND ALLERGIC DISEASES | MOREAU, NASHARA LOUISE | 1655 | §103 | Final Rejection | — | Pending | Dec 18, 2023 |
| 18485314 | NOVEL BACILLUS VELEZENSIS GYUN-1190 STRAIN AND USE THEREOF | KARUNASENA, ENUSHA | 1653 | §101§102§103§112 | Non-Final OA | 19d overdue | Pending | Oct 12, 2023 |
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 1655 | §101§102§103 | Final Rejection | 50d | Pending | Feb 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial